Antiphospholipid antibodies in pregnancy: prevalence and clinical associations
暂无分享,去创建一个
[1] N. Pattison,et al. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations , 1993, British journal of obstetrics and gynaecology.
[2] T. Chard,et al. The myth of fetal growth retardation at term , 1993, British journal of obstetrics and gynaecology.
[3] A. DeMichele,et al. Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss. , 1993, Blood.
[4] I. Sargent,et al. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre‐eclamptic women on the growth of endothelial cells in vitro , 1993, British journal of obstetrics and gynaecology.
[5] P. Fishman,et al. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. , 1993, The Journal of clinical investigation.
[6] N. Rote,et al. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. , 1992, Journal of reproductive immunology.
[7] D. Kilpatrick,et al. Obstetric significance of cardiolipin antibodies in subjects without systemic lupus erythematosus , 1992 .
[8] D. Kilpatrick. Pre‐eclampsia and anti‐phospholipid antibody , 1991 .
[9] C. Redman,et al. Pre‐eclampsia and anti‐phospholipid antibody , 1991, British journal of obstetrics and gynaecology.
[10] H. Brown,et al. Anticardiolipin antibodies in unselected pregnant women. Relationship to fetal outcome. , 1991, Journal of perinatology : official journal of the California Perinatal Association.
[11] D. Kilpatrick,et al. ANTI-PHOSPHOLIPID ANTIBODY SYNDROME AND PRE-ECLAMPSIA , 1989, The Lancet.
[12] J. Hobbins,et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. , 1989, American journal of obstetrics and gynecology.